Back to Search Start Over

PCN2 Recurrences Avoided and Life Years Saved Attributable to Trastuzumab Use in HER2+ Early and Metastatic Breast Cancer in the United States.

Authors :
Danese, M.
Doan, Q.
Antao, V.
Sussell, J.
Source :
Value in Health. 2021 Supplement 1, Vol. 24, pS19-S19. 1p.
Publication Year :
2021

Details

Language :
English
ISSN :
10983015
Volume :
24
Database :
Academic Search Index
Journal :
Value in Health
Publication Type :
Academic Journal
Accession number :
150694110
Full Text :
https://doi.org/10.1016/j.jval.2021.04.094